Beneficial effect of interferon-β 1b treatment in patients with relapsing–remitting multiple sclerosis is associated with an increase in serum levels of soluble HLA-I molecules during the first 3 months of therapy
Enrico Fainardi, Roberta Rizzo, Loredana Melchiorri, Massimiliano Castellazzi, Vittorio Govoni, Luisa Caniatti, Ezio Paolino, Maria Rosaria Tola, Enrico Granieri, Olavio Roberto BaricordiVolume:
148
Year:
2004
Language:
english
Pages:
6
DOI:
10.1016/j.jneuroim.2003.12.002
File:
PDF, 154 KB
english, 2004